Graviti Pharmaceuticals Private Limited recalls Bupropion…
Graviti Pharmaceuticals Private Limited recalls Bupropion Hydrochloride Extended-Release Tablets USP (XL)
- Published
- 29 Oct 2025
- Units affected
- 46,512/30 count bottles
- Agency
- FDA
- Country
- United States
The hazard
Failed Tablet/Capsule Specifications
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.
- Brand / company
- Graviti Pharmaceuticals Private Limited
- Codes / lots
- Batch # BPB124341A, Exp date: 10/2026
- Distribution
- Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 29 Oct 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.